Furthermore, we grouped the CLL/SLL patients into a classic group and an atypical group according to the CLL/SLL RMH scoring system, and we found that MYD88 (p < 0.001) was predominant in the atypical group of patients (Figure 2C). Here, MYD88 is linked to B-cell chronic lymphocytic leukemia.